Engineered dendritic cells and uses for the treatment of cancer

Details for Australian Patent Application No. 2008311292 (hide)

Owner University of Pittsburgh of the Commonwealth System of Higher Education Intrexon Corporation

Inventors Okada, Hideho; Storkus, Walter J.; Braughler, J. Mark; Kumar, Prasanna

Agent Spruson & Ferguson

Pub. Number AU-A-2008311292

PCT Pub. Number WO2009/048560

Priority 60/990,167 26.11.07 US; 60/978,509 09.10.07 US; 60/990,689 28.11.07 US; 61/019,089 04.01.08 US; 60/978,394 08.10.07 US; 60/991,807 03.12.07 US; 60/979,480 12.10.07 US; 60/979,485 12.10.07 US; 60/978,224 08.10.07 US

Filing date 8 October 2008

Wipo publication date 16 April 2009

International Classifications

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/048560 Priority application(s): WO2009/048560

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008311306-Secure wireless communication

2008311289-Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof